Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: A 10-year, single-institution cohort study

JAMA Dermatology

Volumn 149, Issue 5, 2013, Pages 541-547

  Schmults, Chrysalyne D ^a   Karia, Pritesh S ^a   Carter, Joi B ^b   Han, Jiali ^a   Qureshi, Abrar A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SKIN CARCINOMA; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR LOCALIZATION; TUMOR VOLUME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BOSTON; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; TUMOR BURDEN;

EID: 84877868040     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2013.2139     Document Type: Article

References (26)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30(5, pt 1):774-778. (Pubitemid 24157120)
2. Joseph MG, Zulueta WP, Kennedy PJ. Squamous cell carcinoma of the skin of the trunk and limbs: the incidence of metastases and their outcome. Aust N Z J Surg. 1992;62(9):697-701.
3. Brantsch KD, Meisner C, Schönfisch B, et al. Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol. 2008;9(8):713-720.
4. Chuang TY, Popescu NA, SuWP,Chute CG. Squamous cell carcinoma: a population-based incidence study in Rochester, Minn. Arch Dermatol. 1990;126(2):185-188. (Pubitemid 20055687)
5. Czarnecki D, Staples M, Mar A, Giles G, Meehan C. Metastases from squamous cell carcinoma of the skin in southern Australia. Dermatology. 1994;189(1):52-54. (Pubitemid 24126372)
6. Epstein E, Epstein NN, Bragg K, Linden G. Metastases from squamous cell carcinomas of the skin. Arch Dermatol. 1968;97(3):245-251.
7. Katz AD, Urbach F, Lilienfeld AM. The frequency and risk of metastases in squamous-cell carcinoma of the skin. Cancer. 1957;10(6):1162-1166.
8. Møller R, Reymann F, Hou-Jensen K. Metastases in dermatological patients with squamous cell carcinoma. Arch Dermatol. 1979;115(6):703-705. (Pubitemid 9249657)
9. Mourouzis C, Boynton A, Grant J, et al. Cutaneous head and neck SCCs and risk of nodal metastasis: UK experience. J Craniomaxillofac Surg. 2009;37(8):443-447.
10. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol. 2005;23(4):759-765. (Pubitemid 46237442)
11. Mullen JT, Feng L, Xing Y, et al. Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol. 2006;13(7):902-909.
12. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976-990.
13. Dauendorffer JN, Bastuji-Garin S, Guéro S, Brousse N, Fraitag S. Shrinkage of skin excision specimens: formalin fixation is not the culprit. Br J Dermatol. 2009;160(4):810-814.
14. Hudson-Peacock MJ,Matthews JN, Lawrence CM. Relation between size of skin excision, wound, and specimen. J Am Acad Dermatol. 1995;32(6):1010-1015.
15. Kerns MJ, Darst MA, Olsen TG, Fenster M, Hall P, Grevey S. Shrinkage of cutaneous specimens: formalin or other factors involved? J Cutan Pathol. 2008;35(12):1093-1096.
16. Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assn. 1999;94(446):496-509.
17. Kalbfleisch DJ, Prentice LR. The Statistical Analysis of Failure Time Data. Hoboken, NJ: John Wiley & Sons; 2002.
18. Cutaneous squamous cell carcinoma and other cutaneous carcinomas. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010:1-646.
19. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: basal and squamous cell skin cancers. 2010. http://www.nccn.org/ professionals/physician-gls/pdf/nmsc.pdf. Accessed June 27, 2012.
20. Jambusaria-Pahlajani A, Miller CJ, Quon H, Smith N, Klein RQ, Schmults CD. Surgical monotherapy versus surgery plus adjuvant radiotherapy in high risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg. 2009;35(4):574-585.
21. Ross AS, Schmults CD. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: a systematic review of the English literature. Dermatol Surg. 2006;32(11):1309-1321. (Pubitemid 44691132)
22. Jambusaria-Pahlajani A, Hess SD, Katz KA, Berg D, Schmults CD. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Arch Dermatol. 2010;146(11):1224-1231.
23. Goepfert H, Dichtel WJ, Medina JE, Lindberg RD, Luna MD. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg. 1984;148(4):542-547.
24. Veness MJ, Morgan GJ, Palme CE, Gebski V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope. 2005;115(5):870-875. (Pubitemid 40604696)
25. Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg. 2007;33(8):885-899. (Pubitemid 47106729)
26. Lansbury L, Leonardi-Bee J, Perkins W, Goodacre T, Tweed JA, Bath-Hextall FJ. Interventions for non-metastatic squamous cell carcinoma of the skin. Cochrane Database Syst Rev. 2010;(4):CD007869.